(211) found that CD58 was highly expressed in CRC, CD58-positive tumor cells were frequently present in primary specimens and CRC cell lines, and demonstrated increased tumorigenicity in vitro and in vivo. The gene discussed is CD58; the disease is colorectal carcinoma.